Insider · CIK 0001238646

GARDNER PHYLLIS

Reports to the SEC for 4 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001238646

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-13	MDXGMIMEDX GROUP, INC.A Award	Director	AAward	+35.4K sh	$4.95	+$175K	117,024
2022-06-07	MDXGMIMEDX GROUP, INC.A Award	Director	AAward	+44.2K sh	$3.96	+$175K	81,670
2021-05-27	MDXGMIMEDX GROUP, INC.A Award	Director	AAward	+17.1K sh	$10.26	+$175K	37,479
2021-04-28	MDXGMIMEDX GROUP, INC.A Award	Director	AAward	+16.3K sh	$10.71	+$175K	16,339
2021-04-28	MDXGMIMEDX GROUP, INC.A Award	Director	AAward	+4,084 sh	$10.71	+$43.7K	20,423
2021-04-26	CohBar, Inc.Stock Option (Right to buy)A Award	Director	AAward	+200K sh	—	—	200,000
2020-05-14	Revance Therapeutics, Inc.A Award	Director	AAward	+6,000 sh	—	—	16,500
2020-05-14	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2019-05-09	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2019-05-09	Revance Therapeutics, Inc.A Award	Director	AAward	+4,500 sh	—	—	10,500
2019-02-08	CohBar, Inc.Stock Options (right to buy)A Award	Director	AAward	+200K sh	—	—	200,000
2018-11-27	Corium International, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−34.2K sh	$12.50	−$428K	0
2018-11-27	Corium International, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	$12.50	−$188K	0
2018-11-27	Corium International, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	$12.50	−$150K	0
2018-11-27	Corium International, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	$12.50	−$150K	0
2018-11-27	Corium International, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	$12.50	−$188K	0
2018-11-27	Corium International, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,920 sh	$12.50	−$99K	0
2018-05-10	Revance Therapeutics, Inc.A Award	Director	AAward	+3,000 sh	—	—	6,000
2018-05-10	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2018-03-16	Revance Therapeutics, Inc.S Sale	Director	SSale	−5,333 sh	$31.51	−$168K	3,000
2018-03-16	Revance Therapeutics, Inc.Common StockM Exercise/Conversion	Director	MExercise/Conversion	+1,333 sh	—	—	0
2018-03-16	Revance Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,333 sh	$2.55	+$3,399.15	8,333
2018-03-16	Revance Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	$2.55	+$10.2K	7,000
2018-03-16	Revance Therapeutics, Inc.Common StockM Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	—	—	0
2017-12-01	Corium International, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2017-08-21	Corium International, Inc.Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−33.1K sh	—	—	0
2017-08-21	Corium International, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+33.1K sh	$2.12	+$70.1K	34,203
2017-05-11	Revance Therapeutics, Inc.A Award	Director	AAward	+3,000 sh	—	—	3,000
2017-05-11	Revance Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2016-12-22	Corium International, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2016-05-05	Revance Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2015-12-18	Corium International, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2015-05-07	Revance Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2015-03-27	Corium International, Inc.Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+1,139 sh	—	—	0
2015-03-27	Corium International, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,139 sh	$0.20	+$230.078	1,139
2014-12-04	Corium International, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2014-02-11	Revance Therapeutics, Inc.Series E-3 Convertible Preferred StockC Conversion	Director	CConversion	−116K sh	—	—	0
2014-02-11	Revance Therapeutics, Inc.Series E-4 Convertible Preferred StockC Conversion	Director	CConversion	−47.3K sh	—	—	0
2014-02-11	Revance Therapeutics, Inc.C Conversion	Director	CConversion	+41.3K sh	—	—	444,246
2014-02-11	Revance Therapeutics, Inc.Warrant to Purchase Common StockX Exercise of In-Money	Director	XExercise of In-Money	−12.8K sh	—	—	0
2014-02-11	Revance Therapeutics, Inc.C Conversion	Director	CConversion	+403K sh	—	—	402,934
2014-02-11	Revance Therapeutics, Inc.Convertible Promissory NotesC Conversion	Director	CConversion	−41.3K sh	—	—	0
2014-02-11	Revance Therapeutics, Inc.X Exercise of In-Money	Director	XExercise of In-Money	+12.8K sh	—	—	457,085
2014-02-11	Revance Therapeutics, Inc.Series E-1 Convertible Preferred StockC Conversion	Director	CConversion	−125K sh	—	—	0
2014-02-11	Revance Therapeutics, Inc.Series E-2 Convertible Preferred StockC Conversion	Director	CConversion	−115K sh	—	—	0

Recent filings

Accepted (ET)
Jun 154
GARDNER PHYLLIS0001376339-23-000040
SEC(opens sec.gov)
Jun 134
GARDNER PHYLLIS0001376339-22-000091
SEC(opens sec.gov)
May 284
GARDNER PHYLLIS0001376339-21-000075
SEC(opens sec.gov)
Apr 294
GARDNER PHYLLIS0001376339-21-000034
SEC(opens sec.gov)
Apr 284
GARDNER PHYLLIS0001213900-21-023261
SEC(opens sec.gov)
May 154
GARDNER PHYLLIS0001479290-20-000067
SEC(opens sec.gov)
May 104
GARDNER PHYLLIS0001479290-19-000058
SEC(opens sec.gov)
Feb 124
GARDNER PHYLLIS0001209191-19-009183
SEC(opens sec.gov)
Nov 284
GARDNER PHYLLIS0001567619-18-007065
SEC(opens sec.gov)
May 114
GARDNER PHYLLIS0001479290-18-000079
SEC(opens sec.gov)
Mar 164
GARDNER PHYLLIS0001479290-18-000054
SEC(opens sec.gov)

Companies

Address

C/O ESSEX WOODLANDS HEALTH VENTURES 335 BRYANT STREET, THIRD FLOOR

PALO ALTO, CA, 94301